Current Opinion in Pharmacology

Papers
(The H4-Index of Current Opinion in Pharmacology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Therapeutic hurdles in acute myeloid leukemia: Leukemic stem cells, inflammation and immune dysfunction115
Corrigendum to “From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling” [COPHAR 76 (2024) 102458]109
Editorial Board96
Native botulinum toxin type A vs. redesigned botulinum toxins in pain: What did we learn so far?80
From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling68
Lipid raft disruption as an opportunity for peripheral analgesia52
The role of extracellular ATP in homeostatic immune cell migration52
The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathies47
Recent advances in emerging PCOS therapies45
Considerations for individualized first-line systemic treatment in advanced hepatocellular carcinoma41
Optofluidic neural interfaces for in vivo photopharmacology40
Photo-isomerizable tweezers to probe ionotropic receptor mechanisms38
Editorial Board38
Gastrointestinal issue: Advances in gastrointestinal oncology36
CRISPR-Cas9 in acute myeloid leukaemia: current state-of-art and future perspectives34
Optic nerve regeneration: Potential treatment approaches34
Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis33
Editorial overview: Special issue on “Rheumatology: Therapeutic advances for autoimmune and musculoskeletal diseases”32
Editorial Board31
Advanced microneedle arrays for transdermal antibiotic delivery31
Pharmaceutical therapies targeting autophagy for the treatment of age-related macular degeneration31
Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus28
Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance28
Three-dimensional culture models to study glioblastoma — current trends and future perspectives28
Paeoniflorin is a promising natural monomer for neurodegenerative diseases via modulation of Ca2+ and ROS homeostasis27
Current state of CFTR modulators for treatment of Cystic Fibrosis27
Allogeneic double-negative T-cell therapy for acute myeloid leukemia27
0.57696485519409